BSE Live
Oct 03, 14:23Prev. Close
1327.80
Open Price
1330.05
Bid Price (Qty.)
1313.85 (12)
Offer Price (Qty.)
1315.85 (4)
NSE Live
Oct 03, 14:23Prev. Close
1327.30
Open Price
1337.00
Bid Price (Qty.)
1314.30 (1)
Offer Price (Qty.)
1314.80 (5)
Key Financial Ratios of Ipca Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 35.14 | 25.82 | 18.58 | 34.85 | 45.01 | |
Diluted EPS (Rs.) | 29.08 | 21.57 | 18.58 | 34.85 | 45.01 | |
Cash EPS (Rs.) | 46.72 | 34.94 | 29.70 | 45.07 | 107.06 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 273.88 | 304.57 | 233.16 | 219.51 | 371.79 | |
Book Value [InclRevalReserve]/Share (Rs.) | 273.88 | 304.57 | 233.16 | 219.51 | 371.79 | |
Revenue from Operations/Share (Rs.) | 352.37 | 303.71 | 246.13 | 229.79 | 427.28 | |
PBDIT/Share (Rs.) | 71.70 | 56.99 | 41.48 | 54.23 | 126.70 | |
PBIT/Share (Rs.) | 56.02 | 42.91 | 31.17 | 45.07 | 110.21 | |
PBT/Share (Rs.) | 44.59 | 33.22 | 29.38 | 44.77 | 109.50 | |
Net Profit/Share (Rs.) | 31.04 | 20.86 | 19.39 | 35.91 | 90.57 | |
NP After MI And SOA / Share (Rs.) | 29.08 | 21.57 | 18.58 | 34.85 | 89.87 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 20.34 | 18.76 | 16.85 | 23.59 | 29.65 | |
PBIT Margin (%) | 15.89 | 14.12 | 12.66 | 19.61 | 25.79 | |
PBT Margin (%) | 12.65 | 10.93 | 11.93 | 19.48 | 25.62 | |
Net Profit Margin (%) | 8.80 | 6.86 | 7.87 | 15.62 | 21.19 | |
NP After MI And SOA Margin (%) | 8.25 | 7.10 | 7.54 | 15.16 | 21.03 | |
Return on Networth/Equity (%) | 10.61 | 8.64 | 8.06 | 16.09 | 24.24 | |
Return on Capital Employed (%) | 15.15 | 12.44 | 11.59 | 18.52 | 28.48 | |
Return on Assets (%) | 6.27 | 4.93 | 5.46 | 11.57 | 18.78 | |
Total Debt/Equity (X) | 0.19 | 0.22 | 0.25 | 0.14 | 0.05 | |
Asset Turnover Ratio (%) | 0.78 | 0.78 | 0.77 | 0.80 | 0.91 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 2.63 | 2.35 | 2.87 | 3.04 | 2.96 | |
Quick Ratio (X) | 1.55 | 1.30 | 1.91 | 1.77 | 1.59 | |
Inventory Turnover Ratio (X) | 3.55 | 1.05 | 0.95 | 0.96 | 1.10 | |
Dividend Payout Ratio (NP) (%) | 13.75 | 9.27 | 21.53 | 11.47 | 8.90 | |
Dividend Payout Ratio (CP) (%) | 8.93 | 5.60 | 13.84 | 9.08 | 7.52 | |
Earnings Retention Ratio (%) | 86.25 | 90.73 | 78.47 | 88.53 | 91.10 | |
Cash Earnings Retention Ratio (%) | 91.07 | 94.40 | 86.16 | 90.92 | 92.48 | |
Coverage Ratios | ||||||
Interest Coverage Ratios (%) | 21.42 | 10.46 | 23.11 | 178.91 | 177.79 | |
Interest Coverage Ratios (Post Tax) (%) | 21.42 | 10.46 | 23.11 | 178.91 | 177.79 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 40,485.27 | 33,899.87 | 20,234.90 | 27,148.88 | 24,038.82 | |
EV/Net Operating Revenue (X) | 4.53 | 4.40 | 3.24 | 4.66 | 4.44 | |
EV/EBITDA (X) | 22.26 | 23.45 | 19.23 | 19.73 | 14.96 | |
MarketCap/Net Operating Revenue (X) | 4.26 | 4.08 | 3.29 | 4.62 | 4.45 | |
Retention Ratios (%) | 86.24 | 90.72 | 78.46 | 88.52 | 91.09 | |
Price/BV (X) | 5.48 | 4.96 | 3.52 | 4.90 | 5.13 | |
Price/Net Operating Revenue | 4.26 | 4.08 | 3.29 | 4.62 | 4.45 | |
Earnings Yield | 0.02 | 0.02 | 0.02 | 0.03 | 0.05 |
05.09.2025
Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y
13.08.2025
Accumulate Ipca Laboratories; target of Rs 1525: Prabhudas Lilladher
10.06.2025
Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y
03.06.2025
Ipca Labs Consolidated March 2025 Net Sales at Rs 2,246.69 crore, up 10.51% Y-o-Y
05.09.2025
Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y
10.06.2025
Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y
03.06.2025
Ipca Labs Consolidated March 2025 Net Sales at Rs 2,246.69 crore, up 10.51% Y-o-Y
04.03.2025
Ipca Labs Consolidated December 2024 Net Sales at Rs 2,245.37 crore, up 9.38% Y-o-Y
13.07.2022
Ipca Lab Q1 PAT may dip 41.4% YoY to Rs 179.8 cr: ICICI Direct
08.07.2022
Ipca Laboratories Q1 PAT may dip 36.5% YoY to Rs 194.9 cr: Prabhudas Lilladher
14.04.2022
Ipca Laboratories Q4 PAT may dip 12% YoY to Rs 141.9 cr: Prabhudas Lilladher
13.01.2022
Ipca Laboratories Q3 PAT may dip 32.4% YoY to Rs 179.6 cr: Prabhudas Lilladher